TW246642B - Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme - Google Patents
Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzymeInfo
- Publication number
- TW246642B TW246642B TW82101976A TW82101976A TW246642B TW 246642 B TW246642 B TW 246642B TW 82101976 A TW82101976 A TW 82101976A TW 82101976 A TW82101976 A TW 82101976A TW 246642 B TW246642 B TW 246642B
- Authority
- TW
- Taiwan
- Prior art keywords
- vaccinal
- pharmaceutical
- gastric acid
- inhibiting activity
- reduction caused
- Prior art date
Links
Abstract
An enteric pharmaceutical or vaccinal microcapsule composition, which comprises a medicine or vaccine and a polymer containing carboxyl group; which is characterized in that an additional animal serum is added into the composition in which the weight ratio of the medicine or vaccine : polymer containing carboxyl group : animal serum is 1:2.0:0.2 to 1:10:10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW82101976A TW246642B (en) | 1993-03-17 | 1993-03-17 | Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW82101976A TW246642B (en) | 1993-03-17 | 1993-03-17 | Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
TW246642B true TW246642B (en) | 1995-05-01 |
Family
ID=51401126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW82101976A TW246642B (en) | 1993-03-17 | 1993-03-17 | Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW246642B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957202B2 (en) | 2011-12-15 | 2015-02-17 | Industrial Technology Research Institute | Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same |
-
1993
- 1993-03-17 TW TW82101976A patent/TW246642B/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957202B2 (en) | 2011-12-15 | 2015-02-17 | Industrial Technology Research Institute | Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE862404L (en) | Hydroxamic acid derivatives | |
AU6819294A (en) | Oral drug delivery compositions and methods | |
EP0414263A3 (en) | Lactamfree cyclic aminoacids | |
EP0454044A3 (en) | Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance | |
GR3004448T3 (en) | ||
ZA894128B (en) | Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained | |
AU614726B2 (en) | Substituted alpha-amino acids, their preparation and pharmaceutical compositions containing them | |
DE3766200D1 (en) | L-DOPA CONTAINING MEDICINAL PRODUCT. | |
HUP9800049A3 (en) | Amino acid compositions and use thereof in clinical nutrition, and use of the said amino acids for preparing pharmaceutical compns. for the diminution of tnf | |
EP0233013A3 (en) | Modified enzyme | |
BG102556A (en) | Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases | |
ZA796154B (en) | Tablets | |
EP0395382A3 (en) | Macromolecular endoplasmic reticulum | |
ZA943920B (en) | Pharmaceutical compositions | |
TW246642B (en) | Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme | |
IL87876A0 (en) | Catechol carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
GB2201676B (en) | Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it | |
IL85776A (en) | Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system | |
DK166343C (en) | IMPROVED PIROXICAM CONTAINING MEDICINE | |
IE872239L (en) | Pyridopyrimidinediones and quinazolines | |
NO890174L (en) | RECOMBINANT INTERLEUKIN-1ALFA POLYPEPTIDES. | |
EP0347932A3 (en) | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | |
TH20326A (en) | "Mixture for enhancing the ability to learn" | |
Trautmann et al. | Campylobacter jejuni/coli septicemia. | |
FR2679909B1 (en) | POLYPEPTIDES SUITABLE FOR INDUCING IN VIVO ANTIBODIES INHIBITING THE INVASION OF RED CELLS BY MEROZOUITES OF P. FALCIPARUM, RELATED PRODUCTS AND THEIR APPLICATION AS VACCINES. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |